| __timestamp | Incyte Corporation | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 3004000 | 2395000 |
| Thursday, January 1, 2015 | 26972000 | 9057000 |
| Friday, January 1, 2016 | 58187000 | 393000 |
| Sunday, January 1, 2017 | 79479000 | 79309000 |
| Monday, January 1, 2018 | 94123000 | 134428000 |
| Tuesday, January 1, 2019 | 114249000 | 175431000 |
| Wednesday, January 1, 2020 | 131328000 | 124165000 |
| Friday, January 1, 2021 | 150991000 | 121875000 |
| Saturday, January 1, 2022 | 206997000 | 10114000 |
| Sunday, January 1, 2023 | 255000000 | 9206000 |
| Monday, January 1, 2024 | 312068000 |
Data in motion
In the ever-evolving biotech industry, understanding the cost of revenue is crucial for assessing a company's financial health. Incyte Corporation and Wave Life Sciences Ltd. offer a fascinating case study. From 2014 to 2023, Incyte's cost of revenue surged by over 8,300%, peaking at $255 million in 2023. This growth reflects Incyte's expanding operations and increased production costs. In contrast, Wave Life Sciences experienced a more volatile trajectory, with a peak in 2019 at $175 million, followed by a significant drop to just $9 million in 2023. This decline could indicate strategic shifts or operational challenges. The contrasting trends between these two companies highlight the diverse strategies and market conditions within the biotech sector. Investors and analysts should consider these dynamics when evaluating potential opportunities in this field.
Comparing Cost of Revenue Efficiency: Novartis AG vs Wave Life Sciences Ltd.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Incyte Corporation
Cost of Revenue Trends: GSK plc vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Incyte Corporation
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Incyte Corporation vs Dyne Therapeutics, Inc.
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Bio-Techne Corporation vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Exelixis, Inc. and Wave Life Sciences Ltd.'s Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.